We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNET
11226
CALL
VNET Group
VNET
$2.16B
$109K ﹤0.01%
18,100
-48,200
-73% -$285K
DALT
11227
DELISTED
Anfield Diversified Alternatives ETF
DALT
$109K ﹤0.01%
+12,256
New +$117K
LOV
11228
DELISTED
Spark Networks SE American Depositary Shares
LOV
$109K ﹤0.01%
34,129
-38,240
-53% -$98.9K
VLDR
11229
PUT
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$109K ﹤0.01%
113,700
-89,900
-44% -$155K
BLTS
11230
PUT
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
$109K ﹤0.01%
11,100
-62,800
-85% -$619K
AUS.U
11231
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$109K ﹤0.01%
11,096
+100
+0.9% +$987
REV
11232
DELISTED
Revlon, Inc.
REV
$109K ﹤0.01%
20,106
-54,527
-73% -$299K
CRMD icon
11233
CALL
CorMedix
CRMD
$588M
$108K ﹤0.01%
26,900
+4,300
+19% +$16K
CURV icon
11234
CALL
Torrid Holdings
CURV
$219M
$108K ﹤0.01%
25,100
-75,000
-75% -$421K
GORO icon
11235
CALL
Goldgroup Mining
GORO
$207M
$108K ﹤0.01%
66,300
-7,400
-10% -$14.5K
NPCE icon
11236
Neuropace
NPCE
$507M
$108K ﹤0.01%
+21,692
New +$143K
VHC icon
11237
CALL
VirnetX Holding Corp
VHC
$62.8M
$108K ﹤0.01%
4,605
+1,095
+31% +$30.5K
PEGRW
11238
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$108K ﹤0.01%
772,584
-269,723
-26% -$85.2K
GTH
11239
DELISTED
Genetron Holdings Limited ADS
GTH
$108K ﹤0.01%
21,114
-22,047
-51% -$113K
BIOC
11240
CALL
DELISTED
Biocept, Inc.
BIOC
$108K ﹤0.01%
3,817
+1,270
+50% +$57.9K
JOFFU
11241
DELISTED
JOFF Fintech Acquisition Corp. Unit
JOFFU
$108K ﹤0.01%
11,005
-1,058
-9% -$10.4K
AGEN
11242
Agenus
AGEN
$329M
$107K ﹤0.01%
2,810
-22,578
-89% -$820K
BULZ icon
11243
MicroSectors FANG & Innovation 3x Leveraged ETN
BULZ
$336M
$107K ﹤0.01%
28,046
+7,681
+38% +$55.3K
CLBT icon
11244
PUT
Cellebrite
CLBT
$2.79B
$107K ﹤0.01%
+21,000
New +$109K
KUST
11245
PUT
Kustom Entertainment Inc
KUST
$771K
0
EEX
11246
DELISTED
Emerald Holding
EEX
$107K ﹤0.01%
+26,183
New +$84.4K
ERNA icon
11247
Eterna Therapeutics
ERNA
$4.98M
$107K ﹤0.01%
28
+5
+22% +$35.9K
IHRT icon
11248
CALL
iHeartMedia
IHRT
$457M
$107K ﹤0.01%
13,500
-4,800
-26% -$64.7K
MREO
11249
PUT
Mereo BioPharma
MREO
$50.9M
$107K ﹤0.01%
+95,900
New +$74.3K
RCAT icon
11250
CALL
Red Cat Holdings
RCAT
$1.7B
$107K ﹤0.01%
52,400
+10,900
+26% +$21.7K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.